3-{[2-Oxo-2-(4-phenylpiperazin-1-yl)ethyl]thio}-6-pyridin-4-yl[1,2,4]triazolo[4,3-b]pyridazine structure
|
Common Name | 3-{[2-Oxo-2-(4-phenylpiperazin-1-yl)ethyl]thio}-6-pyridin-4-yl[1,2,4]triazolo[4,3-b]pyridazine | ||
|---|---|---|---|---|
| CAS Number | 891111-13-0 | Molecular Weight | 431.5 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H21N7OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 3-{[2-Oxo-2-(4-phenylpiperazin-1-yl)ethyl]thio}-6-pyridin-4-yl[1,2,4]triazolo[4,3-b]pyridazine |
|---|
| Molecular Formula | C22H21N7OS |
|---|---|
| Molecular Weight | 431.5 |
| InChIKey | VJODDVVYNDTLLH-UHFFFAOYSA-N |
| SMILES | O=C(CSc1nnc2ccc(-c3ccncc3)nn12)N1CCN(c2ccccc2)CC1 |
|
Name: qHTS assay for inhibitors of human lactate dehydrogenase
Source: NCGC
Target: N/A
External Id: LDHA
|
|
Name: Primary qHTS Assay for Foot and Mouth Disease Virus Antivirals against NCGC Sytravon ...
Source: NCGC
External Id: stopgo-p2-SytraCBC-dual-FF
|
|
Name: Primary qHTS Assay for Foot and Mouth Disease Virus Antivirals against NCGC Sytravon ...
Source: NCGC
External Id: stopgo-p2-SytraCBC-dual-Ren
|